Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-06

FDA Approved: RIVASTIGMINE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved rivastigmine under an original application from Sandoz Inc, marking the approval of a rivastigmine generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine (Rivastigmine)

Snippet

ORIG AP for RIVASTIGMINE (RIVASTIGMINE)